首页 > 市场调查报告书 > 製药

生技设备生物工艺

亚太地区生物加工市场预测至 2031 年 - 区域分析 - 按产品、营运规模、製程、应用和最终用户

市场调查报告书

商品编码

1597071

亚太地区生物加工市场预测至 2031 年 - 区域分析 - 按产品、营运规模、製程、应用和最终用户

Asia Pacific Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product, Scale of Operation, Process, Application, and End User

出版日期: 2024年10月03日 | 出版商:

The Insight Partners | 英文 168 Pages | 订单完成后即时交付

价格

简介目录图表

2023年亚太生物加工市场价值为54.8887亿美元，预计2031年将达到168.6877亿美元；预计2023年至2031年复合年增长率为15.1%。

个人化医疗需求激增推动亚太生物加工市场

医疗保健产业从一刀切到有针对性的方法的转变正在扩大对个人化医疗的需求。精准医学被认为是解决癌症、神经退化性疾病和罕见遗传疾病等健康问题最有前景的方法之一。个人化药物生产的创新可能会影响整个产业，而针对小批量生产的一次性技术在蛋白质生物生产中具有潜在的应用，特别是在下游製程。个人化和差异化的医疗方法导致了对更广泛产品的需求——其中许多产品针对相对较小的患者群体。因此，可能需要一种根本不同的生物产品生产和交付方法。精准医学利用个体的基因组资讯为特定适应症提供针对性治疗。罕见疾病数量的增加增加了对生物製剂和药物的需求，从而促进了个人化药物的成长。 2019年，FDA批准了约12种个人化药物，以解决疾病的根本原因，并进一步将精准医疗与临床照护结合。此外，政府加强加强个人化医疗研究活动。例如，2020年2月，美国国家人类基因组研究所（NHGRI）宣布建立新的精准医学和基因组学计画。该计划重点关注基因组学和资讯学工具的创新，以更好地诊断和治疗疾病。个人化药物利用遗传学和生物资讯学的进步来针对特定的患者群体并治疗以前无法治疗的疾病。个人化医疗使用生物加工技术来开发客製化疗法。从分离特定细胞到开发针对患者的治疗方法，生物加工步骤对于生产适合每位患者的治疗方法至关重要。因此，预计个人化医疗需求的不断增长将为预测期内生物加工市场的参与者提供重大的成长机会。

亚太地区生物加工市场概况

亚太地区生物加工市场分为中国、日本、印度、韩国、澳洲和亚太地区其他地区。这些国家的市场成长归因于慢性病盛行率的上升和有利的报销政策。此外，市场参与者实施的扩张和产品推出策略预计将有助于该地区生物製程技术市场的成长。 2023年，中国将占据最大的市场份额，而印度预计在预测期内将实现显着的市场复合年增长率。中国的生物製药产业正在经历巨大转变，从以仿製药为中心的格局演变为蓬勃发展的创新中心。此外，新药、高端医疗器材和技术的产业化和应用的进步也有助于中国生物加工市场的成长。因此，越来越多的研究中心、不断增加的政府资助以及市场参与者不断采取的地理扩张措施推动了亚太地区生物加工市场的成长。

亚太地区生物加工市场收入及 2031 年预测（百万美元）

亚太地区生物加工市场细分

亚太地区生物加工市场按产品、营运规模、製程、应用、最终用户和国家进行分类。

根据产品，亚太生物加工市场分为仪器和消耗品及配件。到2023年，仪器仪表领域将占据更大的市场份额。此外，生物反应器细分分为中试规模、全规模和实验室规模。此外，分段层析系统又分为液相层析、气相层析等。此外，消耗品和配件细分为试剂、细胞培养基、层析树脂等。

从营运规模来看，亚太生物加工市场分为商业营运和临床营运。 2023年，商业营运领域占据更大的市场份额。

依製程划分，亚太生物製程市场分为下游生物製程和上游生物製程。到2023年，下游生物製程领域将占据更大的市场份额。

根据应用，亚太生物加工市场分为单株抗体、疫苗、重组蛋白、细胞和基因治疗等。 2023 年，单株抗体细分市场占最大市场。

就最终用户而言，亚太生物加工市场分为生物製药公司、合约製造组织等。 2023 年，生物製药公司细分市场占最大市场。

依国家/地区划分，亚太地区生物加工市场分为中国、印度、日本、韩国、澳洲和亚太地区其他地区。 2023年，中国在亚太生物加工市场份额中占据主导地位。

Getinge AB、Thermo Fisher Scientific Inc、Sartorius AG、Corning Inc、Bio-Rad Laboratories Inc、Merck KGaA、3M Co、Eppendorf SE、Repligen Corp、Entegris Inc、Agilent Technologies Inc 和 Cytiva US LLC。是亚太地区生物加工市场上的一些领先公司。

The transformation of the healthcare industry from one-size-fits-all to a targeted approach is expanding the demand for personalized medicine. Precision medicine is being considered as one of the most promising approaches to tackle health concerns such as cancer, neurodegenerative diseases, and rare genetic conditions. Innovations in the production of personalized medicines are likely to impact the entire sector, and single-use technologies aimed at smaller-volume production have potential applications in protein bioproduction, particularly in downstream processes. Personalized and differentiated approaches to medicine are leading to a need for a wider range of products-many of them for a relatively small group of patients. Therefore, a fundamentally different approach to the production and delivery of biological products may be required. Precision medicine utilizes the genomic information of an individual to offer targeted treatment for a particular indication. The growing number of orphan diseases has increased the demand for biologics and drugs, which has subsequently boosted the growth of personalized medicines. In 2019, the FDA approved ~12 personalized medications for addressing the root causes of disease and further integrated precision medicine with clinical care. Also, increasing government efforts are strengthening personalized medicine research activities. For instance, in February 2020, the National Human Genome Research Institute (NHGRI) announced to establish a new precision medicine and genomics program. This program focuses on the innovation of genomics and informatics tools for better diagnosis and treatment of disease. Personalized medicines leverage advances in genetics and bioinformatics to target specific patient populations and treat previously untreatable diseases. Personalized medicine uses bioprocessing techniques to develop tailored therapies. From isolating specific cells to developing patient-specific treatments, bioprocessing steps are essential for producing treatments tailored to each patient. Therefore, the rising demand for personalized medicine is predicted to offer significant growth opportunities to the players operating in the bioprocessing market during the forecast period.

Asia Pacific Bioprocessing Market Overview

The Asia Pacific bioprocessing market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in these countries is attributed to the rising chronic disease prevalence and favorable reimbursement policies. Moreover, expansion and product launch strategies implemented by market players are expected to contribute to the growth of the bioprocess technology market in the region. China accounted for the largest share of the market in 2023, and India is expected to record a significant CAGR in the market during the forecast period. The biopharmaceutical industry in China is undergoing a tremendous shift, evolving from a generic-focused landscape to a thriving innovation hub. Additionally, progress in industrialization and the application of novel drugs, high-end medical devices, and techniques contribute to the bioprocessing market growth in China. Thus, an increasing number of research centers, rising government funding, and constant initiatives taken by the market players for geographic expansion fuel the bioprocessing market growth in Asia Pacific.

Asia Pacific Bioprocessing Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Bioprocessing Market Segmentation

The Asia Pacific bioprocessing market is categorized into product, scale of operation, process, application, end user, and country.

Based on product, the Asia Pacific bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held a larger market share in 2023. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors subsegment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the subsegment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.

In terms of scale of operation, the Asia Pacific bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held a larger market share in 2023.

By process, the Asia Pacific bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment held a larger market share in 2023.

Based on application, the Asia Pacific bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held the largest market share in 2023.

In terms of end user, the Asia Pacific bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies segment held the largest market share in 2023.

By country, the Asia Pacific bioprocessing market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific bioprocessing market share in 2023.

Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc, and Cytiva US LLC. are some of the leading companies operating in the Asia Pacific bioprocessing market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Bioprocessing Market Landscape

4.1 Ecosystem Analysis
- 4.1.1 List of Vendors in the Value Chain

5. Asia Pacific Bioprocessing Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
- 5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
- 5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:

6. Bioprocessing Market - Asia Pacific Analysis

6.1 Asia Pacific Bioprocessing Market Overview
6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031

7. Asia Pacific Bioprocessing Market Analysis - by Product

7.1 Overview
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
    - 7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
    - 7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
- 7.3.1 Overview
- 7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

8. Asia Pacific Bioprocessing Market Analysis - by Scale of Operation

8.1 Overview
8.2 Commercial Operations
- 8.2.1 Overview
- 8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
- 8.3.1 Overview
- 8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Bioprocessing Market Analysis - by Process

9.1 Overview
9.2 Downstream Bioprocess
- 9.2.1 Overview
- 9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
- 9.3.1 Overview
- 9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Bioprocessing Market Analysis - by Application

10.1 Overview
10.2 Monoclonal Antibodies
- 10.2.1 Overview
- 10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
- 10.3.1 Overview
- 10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
- 10.4.1 Overview
- 10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
- 10.5.1 Overview
- 10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Asia Pacific Bioprocessing Market Analysis - by End User

11.1 Overview
11.2 Biopharmaceutical Companies
- 11.2.1 Overview
- 11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
- 11.3.1 Overview
- 11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
- 11.4.1 Overview
- 11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12. Asia Pacific Bioprocessing Market - Country Analysis

12.1 Asia Pacific
- 12.1.1 Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
  - 12.1.1.1 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.1.1 Overview
  - 12.1.1.2 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.2.1 China: Bioprocessing Market Breakdown, by Product
    - 12.1.1.2.1.1 China: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.2.1.1.1 China: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.2.1.1.2 China: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.2.2 China: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.2.3 China: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.2.4 China: Bioprocessing Market Breakdown, by Process
    - 12.1.1.2.5 China: Bioprocessing Market Breakdown, by Application
    - 12.1.1.2.6 China: Bioprocessing Market Breakdown, by End User
  - 12.1.1.3 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.3.1 Overview
  - 12.1.1.4 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.4.1 India: Bioprocessing Market Breakdown, by Product
    - 12.1.1.4.1.1 India: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.4.1.1.1 India: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.4.1.1.2 India: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.4.1.2 India: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.4.2 India: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.4.3 India: Bioprocessing Market Breakdown, by Process
    - 12.1.1.4.4 India: Bioprocessing Market Breakdown, by Application
    - 12.1.1.4.5 India: Bioprocessing Market Breakdown, by End User
  - 12.1.1.5 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.5.1 Overview
  - 12.1.1.6 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.6.1 Japan: Bioprocessing Market Breakdown, by Product
    - 12.1.1.6.1.1 Japan: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.6.1.1.1 Japan: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.6.1.1.2 Japan: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.6.1.2 Japan: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.6.2 Japan: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.6.3 Japan: Bioprocessing Market Breakdown, by Process
    - 12.1.1.6.4 Japan: Bioprocessing Market Breakdown, by Application
    - 12.1.1.6.5 Japan: Bioprocessing Market Breakdown, by End User
  - 12.1.1.7 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.7.1 Overview
  - 12.1.1.8 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.8.1 South Korea: Bioprocessing Market Breakdown, by Product
    - 12.1.1.8.1.1 South Korea: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.8.1.1.1 South Korea: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.8.1.1.2 South Korea: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.8.1.2 South Korea: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.8.2 South Korea: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.8.3 South Korea: Bioprocessing Market Breakdown, by Process
    - 12.1.1.8.4 South Korea: Bioprocessing Market Breakdown, by Application
    - 12.1.1.8.5 South Korea: Bioprocessing Market Breakdown, by End User
  - 12.1.1.9 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.9.1 Overview
  - 12.1.1.10 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.10.1 Australia: Bioprocessing Market Breakdown, by Product
    - 12.1.1.10.1.1 Australia: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.10.1.1.1 Australia: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.10.1.1.2 Australia: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.10.1.2 Australia: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.10.2 Australia: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.10.3 Australia: Bioprocessing Market Breakdown, by Process
    - 12.1.1.10.4 Australia: Bioprocessing Market Breakdown, by Application
    - 12.1.1.10.5 Australia: Bioprocessing Market Breakdown, by End User
  - 12.1.1.11 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.11.1 Overview
  - 12.1.1.12 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.12.1 Rest of APAC: Bioprocessing Market Breakdown, by Product
    - 12.1.1.12.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.12.1.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.12.1.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.12.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.12.2 Rest of APAC: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.12.3 Rest of APAC: Bioprocessing Market Breakdown, by Process
    - 12.1.1.12.4 Rest of APAC: Bioprocessing Market Breakdown, by Application
    - 12.1.1.12.5 Rest of APAC: Bioprocessing Market Breakdown, by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Getinge AB
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Sartorius AG
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Corning Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Merck KGaA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 3M Co
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Eppendorf SE
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Repligen Corp
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Entegris Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Agilent Technologies Inc
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
14.12 Cytiva US LLC
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Asia Pacific Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 35. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 36. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 37. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 38. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 39. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 40. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 41. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 42. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 43. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 44. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 45. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 46. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 47. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 48. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 49. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 50. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 51. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 52. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 53. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 54. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 55. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 56. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 57. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 58. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 59. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 60. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
Table 63. Glossary of Terms, Bioprocessing Market

List Of Figures

Figure 1. Asia Pacific Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Asia Pacific: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 32. Growth Strategies in the Bioprocessing Market